Rare diseases
Investigational molecules
Locations
Back to Italy62 clinical trials in Monserrato, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
ItalyA study of navenibart for long-term safety in patients with hereditary angioedema
ItalyStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
ItalyStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
ItalyStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
ItalyPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
ItalyEfficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations
ItalyItalyStudy to evaluate the efficacy and safety of deucrictibant for the prevention and treatment of angioedema attacks in adults with acquired angioedema
ItalyStudy of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures
ItalyStudy comparing cetuximab with chemotherapy versus bevacizumab with chemotherapy in patients with advanced colorectal cancer who have wild-type RAS and right-sided tumors
ItalyStudy of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on colorectal cancer, breast cancer, and hepatocellular carcinoma. Studies evaluate novel targeted therapies and combination treatments for both early-stage and metastatic diseases.
Multiple trials exploring innovative approaches to cancer treatment, including biomarker-driven therapies and immunotherapy combinations.
Innovative research in rheumatoid arthritis and ulcerative colitis, investigating new biological therapies and treatment combinations to improve patient outcomes.
Focus on developing precision medicine approaches and understanding biomarker-based treatment responses.
Clinical trials examining new treatments for asthma and interstitial lung disease, with emphasis on innovative delivery systems and targeted therapies.
Studies evaluate both established and novel therapeutic approaches for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
